US BROKER MOVES: JOYY upgraded at JPM; GAP downgraded at Jefferies
Newsquawk Staff ·
UPGRADES
- Grupo Aval Acciones y Valores (AVAL) Upgraded to Neutral from Underweight at JPMorgan; PT USD 5.50
- Entegris (ENTG) Upgraded to Buy from Hold at Deutsche Bank; PT USD 200 (prev USD 152)
- Hilton Worldwide Holdings (HLT) Upgraded to Buy from Hold at Deutsche Bank; PT USD 365 (prev USD 363)
- IDEX Corporation (IEX) Upgraded to Outperform from Neutral at Mizuho; PT USD 280 (prev USD 210)
- Intuitive Surgical (ISRG) Upgraded to Outperform from Perform at Oppenheimer; PT USD 500
- JOYY (JOYY) Upgraded to Overweight from Neutral at JPMorgan; PT USD 98 (prev USD 35)
- Merck & Co. (MRK) Upgraded to Outperform from Neutral at Daiwa Securities; PT USD 143 (prev USD 120)
- Okta (OKTA) Upgraded to Market Outperform from Market Perform at Citizens; PT USD 170
- Summit Therapeutics (SMMT) Upgraded to Market Perform from Underperform at Leerink; PT USD 13
DOWNGRADES
- Amerant Bancorp (AMTB) Downgraded to Equal Weight from Overweight at Stephens
- Apogee Therapeutics (APGE) Downgraded to Neutral from Buy at BTIG
- Atai Life Sciences (ATAI) Downgraded to Hold from Buy at Deutsche Bank; PT USD 8 (prev USD 12)
- Cardiff Oncology (CRDF) Downgraded to Market Perform from Outperform at William Blair
- Gap (GAP) Downgraded to Hold from Buy at Jefferies; PT USD 23 (prev USD 29)
- MarineMax (HZO) Downgraded to Hold from Buy at Truist Securities
- MarineMax (HZO) Downgraded to Neutral from Buy at Northcoast
- Legend Biotech (LEGN) Downgraded to Perform from Outperform at Oppenheimer; PT USD 40 (prev USD 75)
- Novo Nordisk (NVO) Downgraded to Hold from Buy at Berenberg; PT USD 47 (prev USD 50)
- On Holding (ONON) Downgraded to Outperform from Strong Buy at Raymond James; PT USD 38 (prev USD 52)
- Tencent Music Entertainment (TME) Downgraded to Hold from Buy at China Merchants Securities
- Tencent Music Entertainment (TME) Downgraded to Hold from Buy at China Renaissance; PT USD 9.30
- Tigo Energy (TYGO) Downgraded to Neutral from Buy at Roth
- WSFS Financial (WSFS) Downgraded to Equal Weight from Overweight at Stephens
INITIATIONS
- Flutter Entertainment (FLUT) Initiated Neutral at JPMorgan; PT USD 114
- JSPR Initiated Overweight at Piper Sandler; PT USD 2
- LightPath Technologies (LPTH) Initiated Overweight at Piper Sandler; PT USD 15
- Mercury Systems (MRCY) Initiated Overweight at Piper Sandler; PT USD 126
- QMLS Initiated Buy at Chardan; PT USD 24.50
- Unusual Machines (UMAC) Initiated Overweight at Piper Sandler; PT USD 38
What it means
Daily rating roundups of this kind rarely move index-level pricing; their information content concentrates in single names, and within those the size of the price-target revision rather than the rating change itself is the usual driver. The calls that historically generate the larger single-stock moves are those with outsized target resets or a shift across a buy-to-sell boundary, which in this batch sit on the China ADR and small-cap biotech lines, while housekeeping moves on large caps such as the hotel and pharma names tend to fade within the session. Clustering is the other tell: multiple houses moving the same name in the same direction on the same morning, as with the recreational marine and China internet music lines here, typically reflects a shared trigger such as a recent print or guidance cut rather than independent conviction, and follow-through in those names has tended to outlast the one-off contrarian call. Sector reads are weaker on days when the batch is dispersed, as this one is, spanning banks, semis equipment, biotech and consumer. What is worth watching is whether any of the larger target revisions gets seconded by peers in coming sessions, since copycat cycles have historically been the mechanism by which a single call becomes a re-rating.
- Bristol Myers Squibb (BMY) spokesperson says the company has identified the cause of an earlier Car-T safety signal; will look to resume the paused trials in 2027
- Newsquawk Weekly Economic Release 26th - 30th October 2026
- Abbott (ABT) presents new ESMO data showing 30% absolute improvement in sensitivity with the whole-genome sequencing Oncodetect test in colorectal cancer
- US BROKER MOVES: HESM upgraded at Raymond James; NCLH downgraded at JPM
- Bristol-Myers Squibb (BMY) says Iza-Bren reduced the risk of progression or death by 59% in Phase 3 breast cancer study; median PFS 8.2 months vs 4.0 months for chemotherapy; cORR 40.5% vs 20.2%; mDOR 6.9 vs 4.2 months
Related headlines
- US Midterm Preview: Democrats Favoured to Flip the House, Senate Too Close to Call47 min ago
- Week in Focus 26-30th October 2026: FOMC, BoC, RBNZ, ECB, BoJ Policy Decisions, US PCE47 min ago
- The Trump administration plans to introduce voluntary “US Caught Seafood” labels to help consumers identify seafood origins, according to CBS5 hours ago
- US EQUITY OPEN: Breadth poor at the open: Energy leads gains on oil rally, Tech sees slight bounce7 hours ago
- US FDA approves subcutaneous induction regimen for AbbVie’s (ABBV) Skyrizi for adults with moderately to severely active Crohn’s disease1 hour ago
- Newsquawk European Market Wrap - 23rd October 20267 hours ago
- Kimi K3.1 Pro AI model builds GTA VI-style (TTWO) playable game demo in just 10 hours for USD 52, developer claims on X; showcases AI’s ability to generate video game experiences - UNCONFIRMED1 hour ago
- OpenAI expects future AI models to be capable of identifying and exploiting vulnerabilities that are currently unknown, according to a blog post2 hours ago
- Texas Attorney General Ken Paxton sues OpenAI and CEO Sam Altman for lying to users and harming Texans2 hours ago
- OpenAI reveals plans for an in-house exabyte-scale storage system5 hours ago
- Republican Senator Blackburn has raised concerns about Meta’s (META) plans to update its commercial terms, warning that the changes could “exploit American creators and businesses,” according to a letter5 hours ago
- CNBC speculates that Verizon (VZ) would most likely be involved in the context of a partnership with SpaceX (SPCX)6 hours ago
- Ukraine President Zelensky says the Tesla (TSLA)/SpaceX (SPCX) Starlink and Starshield service remains slowed6 hours ago
- Meta (META) says it will extend the implementation date of updated commercial terms to November 20th (prev. October 30th); extension will allow it to explain the changes to partners and stakeholders7 hours ago
- Daily US Equity Opening News: SPCX explores access to 80K US cell sites; OpenAI nears USD 30bln funding at $1.25T valuation8 hours ago